SHARON MAYERS: Open Payments
NPI 1255972253 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$648 in 12 payments from 9 companies in 2025. Trend: 2023 $629 · 2024 $2,325 · 2025 $648
Food & beverage: $648
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 2 | $241 |
| Lilly USA, LLC | 1 | $121 |
| CVRx, Inc. | 1 | $114 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| Novo Nordisk Inc | 1 | $31 |
| Alexion Pharmaceuticals, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $18 |
| PFIZER INC. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: VOQUEZNA, ZEPBOUND, Barostim Neo System, TRELEGY ELLIPTA, Wegovy, STRENSIQ, QULIPTA, NURTEC ODT.
Industry payments across SC — which companies pay providers there.
